1-4 of 4
Mark Lynch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Analysis of Clonal Dynamics in Childhood ALL Reveals a Key Role for Transcriptional Intratumor Heterogeneity in Driving Resistance to Chemotherapy

Virginia A Turati, PhD, José Afonso Guerra-Assunção, PhD, John C Ambrose, PhD, John Brown, PhD, Mike Hubank, PhD, Alex Hobbs, PhD, Mark Lynch, PhD, Bernadett Gaal, PhD, Sarah Inglott, Lucia Conde, PhD, Simon Richardson, MD PhD, Javier Herrero, PhD, Sten Eirik Jacobsen, MD PhD, Tariq Enver, PhD
Journal: Blood
Blood (2016) 128 (22): 606.
https://doi.org/10.1182/blood.V128.22.606.606
Published: 2016
Journal Articles

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

Clinical Trials & Observations
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pégourie, Javier De La Rubia, Laurent Garderet, Kamel Laribi, Alberto Bosi, Roberto Marasca, Jacob Laubach, Ann Mohrbacher, Angelo Michele Carella, Anil K. Singhal, L. Claire Tsao, Mark Lynch, Eric Bleickardt, Ying-Ming Jou, Michael Robbins, Antonio Palumbo
Journal: Blood
Blood (2016) 127 (23): 2833–2840.
https://doi.org/10.1182/blood-2016-01-694604
Published: 2016
Includes: Supplemental data
Journal Articles

Elotuzumab Plus Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: 2-Year Follow-up

Antonio Palumbo, MD, Massimo Offidani, MD, Brigitte Pégourie, Javier De La Rubia, Laurent Garderet, MD, Kamel Laribi, Alberto Bosi, MD, Roberto Marasca, MD, Jacob P. Laubach, MD, Ann Mohrbacher, MD, Angelo Michele Carella, MD, Anil K. Singhal, Mark Lynch, Ying-Ming Jou, Andrzej Jakubowiak, MD PhD
Journal: Blood
Blood (2015) 126 (23): 510.
https://doi.org/10.1182/blood.V126.23.510.510
Published: 2015
Journal Articles

Pharmacokinetics and Safety of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma and Various Levels of Renal Function: Results of a Phase 1b Study

Jesus Berdeja, MD, Sundar Jagannath, MD, Jeffrey Zonder, MD, Ashraf Badros, MD, Jonathan L. Kaufman, MD, Robert Manges, MD, Mark Lynch, PhD, Eric Bleickardt, MD, Prashni Paliwal, PhD, Ravi Vij, MD
Journal: Blood
Blood (2014) 124 (21): 2119.
https://doi.org/10.1182/blood.V124.21.2119.2119
Published: 2014